We reveal that ferroptosis persists from acute to chronic phases after stroke, and auricular vagus nerve stimulation (atVNS) promotes stroke recovery by suppressing ferroptosis through α7 nicotinic acetylcholine receptor activation, providing a promising noninvasive therapeutic strategy for stroke recovery. The gene discussed is CHRNA7; the disease is stroke disorder.